Emerzene utilizes CRISPR technology for the genetic modification of poppies to produce non-addictive pain medications, addressing the opioid addiction crisis. By employing sustainable agricultural practices and a novel water-based extraction process, the company aims to deliver effective pain relief while minimizing environmental impact and production costs.
Funding
$5.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The opioid addiction crisis stems from the use of synthetic opioid-based pain medications. Traditional methods of extracting pain-relieving compounds from poppies often rely on toxic solvents, leading to environmental concerns and higher production costs.
Solution
Emerzene is a biotechnology company that utilizes CRISPR technology and advanced genetics for the genetic modification of poppies to produce non-addictive pain medications. The company employs sustainable agricultural practices and a novel, water-based extraction process to isolate active pharmaceutical ingredients (APIs). This approach aims to deliver effective pain relief while minimizing the risk of addiction, reducing environmental impact, and achieving competitive API production costs. Emerzene's vertically integrated model encompasses poppy cultivation, precision extraction, and clinical studies to develop new treatments.
Target Audience
Emerzene's primary target audience includes pharmaceutical companies seeking to develop and market non-addictive pain medications, as well as patients seeking effective pain relief without the risk of opioid addiction.
Features
- CRISPR-based gene editing for non-addictive poppy breeding
- Sustainable agronomic practices to improve soil health and crop quality
- Novel, water-based extraction process that eliminates the need for toxic solvents
- Vertically integrated operations, from poppy cultivation to API extraction and clinical studies
- Patented sustainable farming practices
- Control of enzymatic processes during alkaloid formation